PRL and pituitary tumor: On the one hand, prolactin enhances PPARγ and C/EBPβ mRNA production and augments adipocytes differentiation in NIH-3T3 cells [95]; on the other hand, TZDs activation of PPARγ inhibits prolactin function in pituitary tumor cells [96].